[Clinical evaluation of hochu-ekki-to on the patients with renal ptosis].
Hochu-ekki-to was administered orally in 2.5 g doses thrice per day to 53 patients who complained of lumbago or lower abdominal discomfort. Its efficacy rate was 53.8% for the patients who complained of lumbago, and 32.3% for the patients who complained of lower abdominal discomfort. Total efficacy rate was 66.0%. Mild adverse effects were observed in 4 patients, but no severe untoward effects was observed.
Horii
A
A
Department of Urology, Osaka Tetsudo Hospital.
Maekawa
M
M
D000328:Adult; D000368:Aged; D001416:Back Pain / Q000188:drug therapy / Q000209:etiology; D004341:Drug Evaluation; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011391:Prolapse
D004365:Drugs, Chinese Herbal